← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 28, 2010Last known activity
Nov 3, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT05924100Lead sponsorPhase 2Nov 3, 2022
- NCT02928419Lead sponsorPhase 2May 1, 2015
- NCT02912208Lead sponsorPhase 2Jun 1, 2011
- NCT05188326Lead sponsorPhase 3Nov 28, 2010
Details
- Last known activity
- Nov 3, 2022